Articles

Early intervention utilizing a team approach is important to successful palliative care, agreed a multidisciplinary panel convened at the National Comprehensive Cancer Network (NCCN) 21st Annual Conference. Read More ›

In this interview, members of The Urology Group discussed the importance of bone health in patients with prostate cancer, including details about the guidelines they use, the impact of prevention, as well as the different therapies they use in their practice. Read More ›

Head and neck lymphedema (HNL) is a common but underrecognized and poorly managed complication of treatment for head and neck cancer, but its accompanying functional impairments can be improved with targeted therapy, according to Jan S. Lewin, PhD. Read More ›

Daclizumab (Zinbryta) has been approved by the US Food and Drug Administration for adults with relapsing forms of multiple sclerosis. The drug is self-administered by the patient monthly, and comes in the form of a long-acting injection. Read More ›

The US Food and Drug Administration has approved Netspot, the first kit for preparation of gallium Ga 68 dotatate injection, for the detection of neuroendocrine tumors in adult and pediatric patients. The injection serves as a radioactive diagnostic agent for positron emission tomography imaging. Read More ›

The first blood test for detecting epidermal growth factor receptor (EGFR) gene mutations in patients with non−small-cell lung cancer (NSCLC) has been approved by the US Food and Drug Administration. The cobas EGFR Mutation Test v2 is a blood-based diagnostic that aids in selecting patients with NSCLC who may benefit from treatment with erlotinib (Tarceva). Read More ›

• Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
• Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma

Read More ›